Well criz is also a MET inhibitor, so it's not impossible that some of its efficacy springs from that. Solid tumors are notably more complicated than a disease like CML, and so you can't extrapolate from preclinical measures to clinical results with anywhere near the same degree of confidence.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.